Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational Design, Synthesis, and In Vitro Evaluation of Novel Piperazine-Based HDAC Inhibitors as Potential Breast Cancer Therapeutics. | Anticancer Agents Med Chem | 2026 | 42152279 | PubTator, text mining | PubMed |
| Idiopathic retinal vasculitis with neovascularisation in Cornelia de Lange syndrome associated with a novel HDAC8 variant. | Ophthalmic Genet | 2026 | 42125777 | PubTator, text mining | PubMed |
| A new class of indole-based HDAC8 inhibitors as potential anti-lung cancer agents: in silico design, synthesis, biological assessment and binding interaction analysis. | RSC Med Chem | 2026 | 42110700 | PubTator, text mining | PubMed |
| Identification of non-hydroxamate histone deacetylase 8 inhibitors using deep learning-based screening of two-dimensional molecular images. | Bioorg Med Chem | 2026 | 42107269 | PubTator, text mining | PubMed |
| HDAC8-mediated CAPZB desuccinylation enhances cytoskeleton remodeling to promote idiopathic pulmonary fibrosis. | Commun Biol | 2026 | 42050207 | PubTator, text mining | PubMed |
| Fair and Square: Design, Synthesis and Biological Evaluations of Squaric Acid Derivatives as Novel HDAC8 Inhibitors. | ChemMedChem | 2026 | 42035225 | PubTator, text mining | PubMed |
| HDAC8 inhibition targets STAT3-MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia. | Leukemia | 2026 | 42014858 | PubTator, text mining | PubMed |
| The role of Luteolin, Naringenin, and Scutellarin in breast cancer by inhibition of HDAC4/HDAC8. | Sci Rep | 2026 | 41986437 | PubTator, text mining | PubMed |
| Histone decrotonylation plays a distinct role in HIV latency. | Sci Adv | 2026 | 41961925 | PubTator, text mining | PubMed |
| Epigenetic regulators polyphenols in neurodegenerative diseases: a promising intervention strategy. | Ann Med | 2026 | 41918250 | PubTator, text mining | PubMed |
| Placental insufficiency markers to assess the risk of non-chromosomal genetic conditions in early-onset fetal growth restriction. | Ultrasound Obstet Gynecol | 2026 | 41906976 | PubTator, text mining | PubMed |
| Lithium ameliorates neural differentiation restoring cell death balance in Cornelia de Lange syndrome 2D and 3D models. | Cell Death Discov | 2026 | 41904182 | PubTator, text mining | PubMed |
| Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment. | Drug Des Devel Ther | 2026 | 41878673 | PubTator, text mining | PubMed |
| The histone acylation network: emerging therapeutic targets for remodeling the epigenetic landscape in pancreatic ductal adenocarcinoma. | Cell Oncol (Dordr) | 2026 | 41874858 | PubTator, text mining | PubMed |
| Recommended Tool Compounds: Isoform- and Class-Specific Histone Deacetylase Inhibitors. | ACS Pharmacol Transl Sci | 2026 | 41852629 | PubTator, text mining | PubMed |
| Current research on adhesion regulating molecule 1: A Review. | Biochem Biophys Res Commun | 2026 | 41825124 | PubTator, text mining | PubMed |
| Determination of the effects of Herpes simplex glycoprotein B on epigenetic alterations in in vitro models of Alzheimer's disease. | J Alzheimers Dis | 2026 | 41823023 | PubTator, text mining | PubMed |
| CBX3:IL1RN Reflects Distinct Cellular States That Defines the Clinical Outcome of Oral Squamous Cell Carcinoma. | Cancer Med | 2026 | 41803005 | PubTator, text mining | PubMed |
| Phosphatases in tumor cell immune escape: a perspective based on the camouflage, coercion, cytoprotection. | Front Cell Dev Biol | 2026 | 41799437 | PubTator, text mining | PubMed |
| Application of 18β-glycyrrhetinic acid Fluorescent probes in cell imaging. | J Enzyme Inhib Med Chem | 2026 | 41797643 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=2